ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
61 461,41
0,94%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Checkmate Pharmaceuticals Inc (CMPI)

  7. Checkmate Pharmaceuticals Inc (CMPI) Actualités

CMPI

Checkmate Pharmaceuticals (CMPI)

Checkmate Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CMPI
DateHeureSourceTitreSymboleSociété
10/06/202214h37Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CMPICheckmate Pharmaceuticals Inc
07/06/202217h40Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
03/06/202217h42Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202216h15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202215h27Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202215h25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202215h17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202215h13Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202214h38Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
26/05/202223h01GlobeNewswire Inc.University of Iowa Holden Comprehensive Cancer Center Presents Preliminary Data from Clinical Trial of Vidutolimod at the 2022 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CMPICheckmate Pharmaceuticals Inc
12/05/202222h50Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CMPICheckmate Pharmaceuticals Inc
12/05/202222h30GlobeNewswire Inc.Checkmate Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:CMPICheckmate Pharmaceuticals Inc
05/05/202222h23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
02/05/202215h17Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:CMPICheckmate Pharmaceuticals Inc
02/05/202213h49Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:CMPICheckmate Pharmaceuticals Inc
29/04/202222h13Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
20/04/202212h02Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:CMPICheckmate Pharmaceuticals Inc
20/04/202205h45TipRanksAnalysts Conflicted on These Healthcare Names: Axsome Therapeutics (AXSM) and Checkmate Pharmaceuticals (CMPI)NASDAQ:CMPICheckmate Pharmaceuticals Inc
19/04/202222h51Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:CMPICheckmate Pharmaceuticals Inc
19/04/202215h46Dow Jones NewsCheckmate Pharmaceuticals Shares Take Flight on Regeneron DealNASDAQ:CMPICheckmate Pharmaceuticals Inc
19/04/202213h47Dow Jones NewsRegeneron to Buy Checkmate Pharmaceuticals for About $250 MillionNASDAQ:CMPICheckmate Pharmaceuticals Inc
19/04/202213h00PR Newswire (US)Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor TypesNASDAQ:CMPICheckmate Pharmaceuticals Inc
12/04/202205h15TipRanksCheckmate Pharmaceuticals (CMPI) Receives a Buy from BTIGNASDAQ:CMPICheckmate Pharmaceuticals Inc
08/04/202219h01GlobeNewswire Inc.Checkmate Pharmaceuticals Presents Clinical Trial Biomarker Data with Vidutolimod at the 2022 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CMPICheckmate Pharmaceuticals Inc
30/03/202213h22Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CMPICheckmate Pharmaceuticals Inc
30/03/202205h06TipRanksAnalysts’ Top Healthcare Picks: Aldeyra Therapeutics (ALDX), Axsome Therapeutics (AXSM)NASDAQ:CMPICheckmate Pharmaceuticals Inc
29/03/202222h30GlobeNewswire Inc.Checkmate Pharmaceuticals Announces Full Year 2021 Financial Results and Provides Business UpdateNASDAQ:CMPICheckmate Pharmaceuticals Inc
08/03/202222h30GlobeNewswire Inc.Checkmate Pharmaceuticals to Present at the 2022 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CMPICheckmate Pharmaceuticals Inc
02/03/202222h11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CMPICheckmate Pharmaceuticals Inc
14/02/202217h57Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CMPICheckmate Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CMPI

Dernières Valeurs Consultées

EU
CS
Axa
EU
SGO
Cie de SaintGobain
NASDAQ
AMZN
Amazon.com
EU
PX4
SBF 120
NYSE
NKE
Nike
EU
VK
Vallourec
EU
DG
Vinci
COIN
BTCUSD
Bitcoin
EU
VIV
Vivendi
USI
USTECH100
US Tech 100
SPI
SP500
S&P 500
EU
GLE
Societe Generale
NYSE
MCD
McDonalds
EU
CAP
Capgemini
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés